Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Breast J. 2021 Feb 18;27(4):314–321. doi: 10.1111/tbj.14205

Table 1.

Clinicopathologic features of 9 patients with breast implant associated anaplastic large cell lymphoma.

Patient Age Reason for Implant Type of Implant Number of Years after Implant Presentation Stage Treatment pSTAT IHC
1 68 IDC Textured 8 Left breast swelling T2 Bilateral complete capsulectomies Positive
2 77 IDC Textured 12 Right breast mass T4, stage IIA Excision and complete capsulectomy Positive
3 61 IDC and ILC Textured 8 Right breast swelling, effusion T1* Bilateral complete capsulectomies N/A
4
58 DCIS Textured 6 Firmness above her left breast implant and change in shape of implant T4N2M0 Capsulectomy and BV-CHP x 6 cycles + consolidative radiotherapy (3060 cGY in 17 fractions) Positive
5 65 IDC Textured 10 Right breast effusion T1* Complete capsulectomy Positive
6 35 Cosmetic Textured 8 Right breast swelling, effusion T1 Bilateral complete capsulectomies N/A
7 51 IDC Textured 6 Left breast swelling, effusion T1, stage IA Bilateral complete capsulectomies Positive
8 66 IDC Textured 11 Cutaneous lesion T4 XRT (15 fractions, total 3000cGY)-, 6 cycles BV-CHOP, SCT Negative
9 50 ILC Textured 6 Left breast swelling, fevers, night sweats T3, stage 1C Bilateral complete capsulectomies Positive

IDC, invasive ductal carcinoma; ILC, invasive lobular carcinoma; DCIS, ductal carcinoma in situ; SCT, stem cell transplant; IHC, Immunohistochemistry;

*

lymphoma confined to fluid only